A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

The Stanford summary backs up the "rare" label with specific numbers: about one myocarditis case per 140,000 people after a ...

Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups ...

As we prepare for the festive season, it’s easy to let COVID boosters fall off our to-do lists. But COVID is still ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...

In July, the FDA updated the warning label for the Pfizer and Moderna Covid vaccines to warn that the risk of myocarditis and pericarditis, inflammation of the membranes surrounding the heart, was ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells-an advance ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

New data highlight liver-encoded delivery of immune modulators as a strategy to mitigate age-related immune dysfunction.